-
1.
公开(公告)号:US20240181028A1
公开(公告)日:2024-06-06
申请号:US18513738
申请日:2023-11-20
Applicant: Pfizer Inc.
Inventor: Catherine Alex , Annaliesa Sybil Anderson , Bishwa Raj Bhetuwal , Zecheng Chen , Kaushik Dutta , Caitlyn Gallagher , Jianxin Gu , Isis Kanevsky , Jin-Hwan Kim , Justin Keith Moran , Suddham Singh , Naveen Surendran , Abhishek Ravindra Vartak , YuYing Yang
CPC classification number: A61K39/092 , A61K47/646
Abstract: The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in Prevnar, Synflorix and/or Prevnar 13. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumoccocal infections using said novel immunogenic compositions.
-
2.
公开(公告)号:US20240325515A1
公开(公告)日:2024-10-03
申请号:US18621962
申请日:2024-03-29
Applicant: Pfizer Inc.
Inventor: Kaushik Dutta , Caitlyn Gallagher , Isis Kanevsky , Jin-hwan Kim , Justin Keith Moran , Suddham Singh , Abhishek Ravindra Vartak
CPC classification number: A61K39/092 , A61K47/42 , A61P31/04 , A61K2039/55505
Abstract: The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates), kits comprising said immunogenic compositions and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.
-